Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios Mikellides

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Heliyon|December 26, 2022
High-frequency rTMS improves quality of life and depressive symptoms in Parkinson's disease: A case reportPanayiota Michael, Sandra Blythin Constantinou Juhasz, Olympia Evagorou, et al.
Frontiers in Psychiatry|January 31, 2022
A Retrospective Naturalistic Study Comparing the Efficacy of Ketamine and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant DepressionGeorgios Mikellides, Panayiota Michael, Lilia Psalta, et al.
Current Aging Science|October 31, 2025
Repetitive Transcranial Magnetic Stimulation in DementiaGeorgios Mikellides, Amir Arshia Emam Jomeh, Eleanor Arati Roy, et al.
The Journal of Nervous and Mental Disease|November 30, 2021
"Sleeping Beauty Syndrome" and Psychosis as Precursory Symptoms of Multiple Sclerosis: A Rare Case and Literature ReviewOlympia Evagorou, Aikaterini Arvaniti, Christina Angelopoulou, et al.
International Journal of Clinical and Health Psychology : IJCHP|November 23, 2022
Accelerated intermittent theta burst stimulation in smoking cessation: No differences between active and placebo stimulation when using advanced placebo coil technology. A double-blind follow-up studyGeorgios Mikellides, Panayiota Michael, Lilia Psalta, et al.
Frontiers in Psychiatry|June 10, 2022
Accelerated Intermittent Theta Burst Stimulation in Smoking Cessation: Placebo Effects Equal to Active Stimulation When Using Advanced Placebo Coil TechnologyGeorgios Mikellides, Panayiota Michael, Lilia Psalta, et al.
Frontiers in Psychiatry|November 29, 2023
Editorial: Alternative treatments to classical antidepressants in treatment-resistant depressionGeorgios Mikellides, Theodoros Koutsomitros, Olympia Evagorou, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Heliyon|December 26, 2022
High-frequency rTMS improves quality of life and depressive symptoms in Parkinson's disease: A case reportPanayiota Michael, Sandra Blythin Constantinou Juhasz, Olympia Evagorou, et al.
Frontiers in Psychiatry|January 31, 2022
A Retrospective Naturalistic Study Comparing the Efficacy of Ketamine and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant DepressionGeorgios Mikellides, Panayiota Michael, Lilia Psalta, et al.
Current Aging Science|October 31, 2025
Repetitive Transcranial Magnetic Stimulation in DementiaGeorgios Mikellides, Amir Arshia Emam Jomeh, Eleanor Arati Roy, et al.
The Journal of Nervous and Mental Disease|November 30, 2021
"Sleeping Beauty Syndrome" and Psychosis as Precursory Symptoms of Multiple Sclerosis: A Rare Case and Literature ReviewOlympia Evagorou, Aikaterini Arvaniti, Christina Angelopoulou, et al.
International Journal of Clinical and Health Psychology : IJCHP|November 23, 2022
Accelerated intermittent theta burst stimulation in smoking cessation: No differences between active and placebo stimulation when using advanced placebo coil technology. A double-blind follow-up studyGeorgios Mikellides, Panayiota Michael, Lilia Psalta, et al.
Frontiers in Psychiatry|June 10, 2022
Accelerated Intermittent Theta Burst Stimulation in Smoking Cessation: Placebo Effects Equal to Active Stimulation When Using Advanced Placebo Coil TechnologyGeorgios Mikellides, Panayiota Michael, Lilia Psalta, et al.
Frontiers in Psychiatry|November 29, 2023
Editorial: Alternative treatments to classical antidepressants in treatment-resistant depressionGeorgios Mikellides, Theodoros Koutsomitros, Olympia Evagorou, et al.
Pageof 2